Yaowei Huang
253 Middle Industrial Avenue
Guangzhou, 510282, China
Guangzhou, 510282, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Prenatal p25-activated Cdk5 induces pituitary tumorigenesis through MCM2 phosphorylation-mediated cell proliferation.
Journal: Neoplasia (New York, N.Y.)
Published: June 24, 2024
Periodontopathic Microbiota and Atherosclerosis: Roles of TLR-Mediated Inflammation Response.
Journal: Oxidative medicine and cellular longevity
Published: January 16, 2022
Characteristics of basilar artery atherosclerotic plaques in pontine infarctions: A high-resolution magnetic resonance imaging study.
Journal: Cerebral circulation - cognition and behavior
Published: November 03, 2020
Cdk5 Inhibitory Peptide Prevents Loss of Neurons and Alleviates Behavioral Changes in p25 Transgenic Mice.
Journal: Journal of Alzheimer's disease : JAD
Published: March 08, 2020
AAV9-Mediated Cdk5 Inhibitory Peptide Reduces Hyperphosphorylated Tau and Inflammation and Ameliorates Behavioral Changes Caused by Overexpression of p25 in the Brain.
Journal: Journal of Alzheimer's disease : JAD
Published: July 01, 2019
Regulation of immune-driven pathogenesis in Parkinson's disease by gut microbiota.
Journal: Brain, behavior, and immunity
Published: May 19, 2019
Vibrio vulnificus meningoencephalitis in a patient with thalassemia and a splenectomy.
Journal: Journal of neurovirology
Published: April 09, 2018
Cdk5 Inhibitory Peptide Prevents Loss of Dopaminergic Neurons and Alleviates Behavioral Changes in an MPTP Induced Parkinson's Disease Mouse Model.
Journal: Frontiers in aging neuroscience
Published: January 10, 2018
Morphologic Damage of Rat Alveolar Epithelial Type II Cells Induced by Bile Acids Could Be Ameliorated by Farnesoid X Receptor Inhibitor Z-Guggulsterone In Vitro.
Journal: BioMed research international
Published: February 10, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026